Based on the knowledge that Syk inhibition, e.g. using Fostamatinib, has beneficial effects in inflammatory diseases, the relevance of Syk in GvHD was further evaluated (Figure 3) (27, 124–126). Here, SYK is linked to graft versus host disease.